In Episode 2 of our 'Tea and Talk' podcast, Dr. Rebekah Widdowfield chats with the CEO of Novabiotics, Dr. Deborah O'Neil about the efficacy of creating drugs, how the vaccine development process works, current efforts being made to produce treatments for COVID-19, and how the current pandemic has affected our approach to global production and collaboration.
Subscribe for a new episode every Friday.
The Royal Society of Edinburgh — @news_RSE
Dr. Rebekah Widdowfield — @Rebekah_RSE
Dr. Deborah O'Neil — @debsoneil | @NovaBiotics
With COP26 being held in Glasgow, we chat to Professor James Curran MBE FRSE and Professor Duncan Maclennan CBE FRSE about the impact of...
We chat with members of the RSE Young Academy of Scotland, Dr Sandro Carnicelli and Dr Leslie Mabon about the impacts of climate change...
We speak to RSE Fellows Professor Maggie Gill and Professor Colin Campbell about land use and climate change. Maggie is Emeritus Professor in the...